Protein & Cell >

2020 , Vol. 11 >Issue 7: 518 - 524

DOI: https://doi.org/10.1007/s13238-020-00700-2

LETTER

Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver

  • Bingbing He 1,3 ,
  • Wenbo Peng 2,3,5 ,
  • Jia Huang 1,3 ,
  • Hang Zhang 2 ,
  • Yingsi Zhou 1 ,
  • Xiali Yang 1 ,
  • Jing Liu 4 ,
  • Zhijie Li 2,3 ,
  • Chunlong Xu 1 ,
  • Mingxing Xue 1 ,
  • Hui Yang , 1 ,
  • Pengyu Huang , 2,5
Expand
  • 1. Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
  • 2. School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
  • 3. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
  • 4. Center for Animal Genomics, Agricultural Genome Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen 518124, China
  • 5. CAS Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China

Published date: 15 Jul 2020

Copyright

2020 The Author(s) 2020
Fold

Cite this article

Bingbing He , Wenbo Peng , Jia Huang , Hang Zhang , Yingsi Zhou , Xiali Yang , Jing Liu , Zhijie Li , Chunlong Xu , Mingxing Xue , Hui Yang , Pengyu Huang . Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver[J]. Protein & Cell, 2020 , 11(7) : 518 -524 . DOI: 10.1007/s13238-020-00700-2

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Chan JC, Piper DE, Cao Q, Liu D, King C, Wang W, Tang J, Liu Q, Higbee J, Xia Z(2009) A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci USA 106:9820–9825

DOI

2
Freije CA, Myhrvold C, Boehm CK, Lin AE, Welch NL, Carter A, Metsky HC, Luo CY, Abudayyeh OO, Gootenberg JS (2019) Programmable inhibition and detection of RNA viruses using Cas13. Mol Cell 76(826–837):e811

DOI

3
Haeusler RA, Hartil K, Vaitheesvaran B, Arrieta-Cruz I, Knight CM, Cook JR, Kammoun HL, Febbraio MA, Gutierrez-Juarez R, Kurland IJ (2014) Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 5:5190

DOI

4
Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635–637

DOI

5
Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD (2018) Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173(665–676):e614

DOI

6
Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK (2012) The PCSK9 decade. J Lipid Res 53:2515–2524

DOI

7
Li P, Ruan X, Yang L, Kiesewetter K, Zhao Y, Luo H, Chen Y, Gucek M, Zhu J, Cao H (2015) A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metab 21:455–467

DOI

8
Moller DE (2012) Metabolic disease drug discovery- “hitting the target” is easier said than done. Cell Metab 15:19–24

DOI

9
Pineda M, Lear A, Collins JP, Kiani S (2019) Safe CRISPR: challenges and possible solutions. Trends Biotechnol 37:389–401

DOI

10
Price AA, Sampson TR, Ratner HK, Grakoui A, Weiss DS (2015) Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc Natl Acad Sci USA 112:6164–6169

DOI

11
Rossidis AC, Stratigis JD, Chadwick AC, Hartman HA, Ahn NJ, Li H, Singh K, Coons BE, Li L, Lv W (2018) In utero CRISPRmediated therapeutic editing of metabolic genes. Nat Med 24:1513–1518

DOI

12
Steinberg D, Witztum JL (2009) Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels. Proc Natl Acad Sci USA 106:9546–9547

DOI

13
Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA (2004) Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 101:2082–2087

DOI

14
Yan WX, Chong S, Zhang H, Makarova KS, Koonin EV, Cheng DR, Scott DA (2018) Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol Cell 70(327–339):e325

DOI

15
Zhou C, Hu X, Tang C, Liu W, Wang S, Zhou Y, Zhao Q, Bo Q, Shi L, Sun X (2020) CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration. Natl Sci Rev.https://doi.org/10.1093/nsr/nwaa033

DOI

Options
Outlines

/

〈 〉